Details for New Drug Application (NDA): 065092
✉ Email this page to a colleague
NDA 065092 describes RANICLOR, which is a drug marketed by Ranbaxy Labs Ltd and is included in one NDA. Additional details are available on the RANICLOR profile page.
The generic ingredient in RANICLOR is cefaclor. There are thirteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefaclor profile page.
The generic ingredient in RANICLOR is cefaclor. There are thirteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefaclor profile page.
Summary for 065092
| Tradename: | RANICLOR |
| Applicant: | Ranbaxy Labs Ltd |
| Ingredient: | cefaclor |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 065092
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | EQ 125MG BASE | ||||
| Approval Date: | Dec 22, 2003 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | EQ 187MG BASE | ||||
| Approval Date: | Dec 22, 2003 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Dec 22, 2003 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
